Aurobindo Pharma Limited vs Commissioner Of Central Excise, … on 25 July, 2025

0
21

[ad_1]

(per the Hon’ble Sri Justice P.Sam Koshy)
Heard Mr. G. Mohan Rao, learned counsel for the appellant, and

Mrs. Pravalika, learned counsel, representing Mr. Dominic Fernandes, learned

Senior Standing Counsel for CBIC for the respondent.

2. The instant is an appeal filed by the appellant / assessee under Section

35(G) of the Central Excise Act, 1944, as substituted by the Finance Act, 2003

challenging the order passed by the Customs, Excise & Service Tax Appellate

Tribunal, South Zonal Bench at Bangalore (in short, the ‘CESTAT’) in

Appeal/Misc.No.E/666/2002, decided on 22.03.2002.

3. Vide the impugned order, the CESTAT dismissed the appeal filed by the

appellant holding that the intermediate product PMCA is not entitled for the

benefit of Notification No.67/95-CE when the final product

‘PYRAZYNAMIDE’ is exempted, in spite of the fact that the product is cleared

on payment of 8% amount in terms of Rule 57CC of the Central Excise Rules,

1944.

[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here